News

Thirteen scholars from the School of Chinese Medicine (SCM) have achieved the remarkable distinction of being listed among the world’s top 2% most-cited scientists in 2025, as announced by Stanford University. This achievement marks a new record high for SCM and highlights the School’s rising research excellence, as well as its expanding impact on the global academic stage.

The ranking compiled by a research team from Stanford University based on Scopus data, assesses the 100,000 top scientists who are classified into 22 scientific fields and 174 sub-fields based on key indicators, including citation impact and research output.

This year, two Chair Professors from the School achieved remarkable success in the field of Complementary & Alternative Medicine. Professor Lyu Aiping, Vice-President (Research and Development) and Professor Bian Zhaoxiang, Associate Vice-President (Clinical Chinese Medicine) were ranked the first and second respectively in China, and 5th and 6^th globally in the single-year citation category.  These accomplishments reflect the School’s prominent academic standing in the international academic community.

SCM extends its heartfelt congratulations to these exemplary scholars. Their accolades have elevated the University’s research profile and reinforced SCM’s leading position in Chinese medicine research. The School is committed to fostering an excellent research environment and driving continuous innovation, contributing meaningful impact to human health.